{{Rsnum
|rsid=7072793
|Gene=IL2RA
|Chromosome=10
|position=6106266
|Orientation=plus
|GMAF=0.4532
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 41.6 | 38.9
| HCB | 38.2 | 47.1 | 14.7
| JPT | 23.0 | 49.6 | 27.4
| YRI | 7.5 | 42.2 | 50.3
| ASW | 7.0 | 45.6 | 47.4
| CHB | 38.2 | 47.1 | 14.7
| CHD | 33.0 | 41.3 | 25.7
| GIH | 24.8 | 48.5 | 26.7
| LWK | 9.2 | 53.2 | 37.6
| MEX | 24.1 | 55.2 | 20.7
| MKK | 17.9 | 46.8 | 35.3
| TSI | 14.0 | 44.0 | 42.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19956099
|Title=The type I diabetes association of the IL2RA locus
|OA=1
}}

{{PMID Auto
|PMID=18840781
|Title=Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=19265545
|Title=Contrasting genetic association of IL2RA with SLE and ANCA-associated vasculitis.
|OA=1
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=22213266
|Title=Functional polymorphism rs7072793 C > T affect individual susceptibility to breast cancer by modulating CD25 transcription activity.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}